Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

France's Ynsect to refocus bug business after capital increase

Published 04/16/2023, 04:04 PM
Updated 04/16/2023, 04:05 PM
© Reuters. FILE PHOTO: Ynsect's Chairman and CEO Antoine Hubert displays mealworms at the laboratory of the insect farm Ynsect, which harvests mealworms for bug-based animal food and fertilizer, in Dole, France, October 22, 2020. REUTERS/Ardee Napolitano

By Sybille de La Hamaide

PARIS (Reuters) - French insect-based ingredients maker Ynsect will refocus its strategy on high-margin markets like pet food, shut a production plant and cut jobs after raising 160 million euros ($177 million) from investors, its chief executive said.

The company, which is in talks for additional funding, will use the money to finance expansion of its flagship vertical insect farm in Amiens in northern France, the world's largest, and for new projects, Antoine Hubert told Reuters in an interview.

Farmed bugs, such as mealworms, are ground down to produce proteins for aquaculture, livestock, pet food, fertilisers and human nutrition. They are considered more environmentally friendly proteins because they require less land and water than crops and emit fewer greenhouse gases.

But the technology is costly, making the meal far more expensive than its plant-based alternatives.

"In an environment where there is inflation on energy and raw materials but also on the cost of capital and debt, we cannot afford to invest loads of resources in markets which are the least remunerative (animal feed), while you have other markets where there is a lot of demand, good returns and higher margins," Hubert said, referring to pet food, human nutrition and fertilisers.

Ynsect will close its Dutch production plant, acquired through the takeover of Protifarm in 2021, which rears a different type of bug, while keeping research activities. This will lead to 35 job cuts.

In addition the company will cut 38 jobs in France, out of a total of about 360 people, Hubert said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ynsect, which announced agreements in December to build insect ingredient production sites in the United States and Mexico, has signed sales deals for 180 million euros over three years and is in talks for an additional 1 billion euros, of which more than half is for pet food, he also said.

In its latest round of fund raising in 2020 Ynsect brought in more than 315 million euros, of which about 175 million euros was capital and the rest in debt and subsidies.

($1 = 0.9051 euros)

Latest comments

No one is eating your bugs klaus not even my dog
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.